Sponsored Program Kit Ordering
The Lantern Project
Sanofi Genzyme is partnering with PerkinElmer Genomics to offer a complimentary genetic testing program called The Lantern Project. This program will provide diagnostic testing for the following lysosomal storage disorders:
- Fabry disease
- Pompe disease
- Gaucher disease
- Niemann─Pick Type A and B (ASMD)
- Mucopolysaccharidosis I (MPS I) and Other MPS Disorders
- Focused Neuromuscular Disease Panel
Ultragenyx Testing Program
Ultragenyx and PerkinElmer Genomics have partnered to offer sponsored MPS panel testing to patients who are suspected of having MPS disorder, or who have been clinically diagnosed with MPS and need confirmatory testing. For Health Care Professionals interested in learning more about the program or ordering collection kits please use links below:
Decode Duchenne provides diagnostic testing for Duchenne and Becker muscular dystrophy. Decode Duchenne is a collaborative partnership between Parent Project Muscular Dystrophy (PPMD), industry partners NS Pharma, Sarepta Therapeutics, PTC Therapeutics and Vertex Pharmaceuticals, and PerkinElmer Genomics.
Identifying the underlying cause of your patient’s chronic anemia can make a big difference to your patient’s life. That’s why Agios Pharmaceuticals has partnered with PerkinElmer Genomics to offer Anemia ID: a free genetic testing program. Anemia ID provides a next-generation sequencing (NGS) panel for a wide range of rare hereditary anemias.
ASAH1 Gene Sequencing
Aceragen is partnering with PerkinElmer Genomics to support no-cost genetic testing of the ASAH1 gene to support the diagnosis of patients with acid ceramidase deficiency. Aceragen is a biopharmaceutical company focused on developing transformative therapies for patients with rare diseases.